← FDA Drug Approvals (Drugs@FDA)
IBUPROFEN AND DIPHENHYDRAMINE CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2022-05-31
Drug application
- FDA Application #
ANDA216204- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBUPROFEN AND DIPHENHYDRAMINE CITRATE
- Generic name
- IBUPROFEN AND DIPHENHYDRAMINE CITRATE
- Active ingredients
- DIPHENHYDRAMINE CITRATE; IBUPROFEN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- KROGER COMPANY
- First approval
- 2022-05-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown